Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein.
BACKGROUND
In vitro and in vivo experiments have demonstrated the role of oxidatively modified low density lipoprotein (oxLDL) in eliciting leukocyte/endothelium interaction during early atherogenesis.


RESULTS
In the present study we investigated the effect of dietary fish oil on oxLDL-induced leukocyte/endothelium interaction using intravital fluorescence microscopy in the dorsal skinfold chamber model in awake Syrian golden hamsters. Hamsters were fed for 4 weeks prior to the experiments with either standard laboratory chow or a diet supplemented with 5% of a fish oil concentrate (18% eicosapentaenoate, 12% docosahexaenoate). The efficacy of the fish oil diet was demonstrated by the incorporation of fish oil-derived omega-3 fatty acids into plasma, leukocyte, and erythrocyte lipids. In control hamsters (n = 7) and fish oil-fed hamsters (n = 7), leukocyte/endothelium interaction was assessed in the time course after intravenous injection of human LDL (4 mg/kg), oxidized by 7.5 microM Cu2+ (6 hours, 37 degrees C). In control hamsters, injection of oxLDL elicited the rolling and sticking of leukocytes to the endothelium of arterioles and postcapillary venules with a maximum 15 minutes after injection (arterioles: from 3 +/- 1 to 91 +/- 25 cells/mm2 at 15 minutes; venules: from 13 +/- 6 to 150 +/- 46 cells/mm2 at 15 minutes; mean +/- SD). This phenomenon was significantly reduced in fish oil-fed hamsters, where 15 minutes after injection of oxLDL leukocyte sticking reached a maximum of only 15 +/- 7 and 20 +/- 5 cells/mm2 in arterioles and postcapillary venules, respectively (p less than 0.01 versus control animals).


CONCLUSIONS
The results of the present study suggest that inhibition of leukocyte/endothelium interaction may be one of the mechanisms by which dietary fish oil exerts its protective effects on experimental and clinical atherogenesis.
Department of Experimental Surgery, University of Heidelberg, Germany.
H A
HA
Lehr
C
C
Hübner
B
B
Finckh
D
D
Nolte
U
U
Beisiegel
A
A
Kohlschütter
K
K
Messmer
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control; D002448:Cell Adhesion / Q000502:physiology; D006224:Cricetinae; D004730:Endothelium, Vascular / Q000502:physiology*; D015525:Fatty Acids, Omega-3 / Q000097:blood; D005395:Fish Oils / Q000494:pharmacology*; D007962:Leukocytes / Q000737:chemistry / Q000502:physiology*; D008077:Lipoproteins, LDL / Q000008:administration & dosage* / Q000378:metabolism; D008647:Mesocricetus; D008856:Microscopy, Fluorescence; D010084:Oxidation-Reduction
D015525:Fatty Acids, Omega-3; D005395:Fish Oils; D008077:Lipoproteins, LDL